Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ReVENT Sleep Apnea System, a Minimally Invasive Approach to Treat Obstructive Sleep Apnea: a Prospective Multicenter Post-Market Observational Study

NCT02180815 is registered in ClinicalTrials.gov with Revent Medical International B.V. as lead sponsor.

NCT NCT02180815
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02180815 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ReVENT Sleep Apnea System, a Minimally Invasive Approach to Treat Obstructive Sleep Apnea: a Prospective Multicenter Post-Market Observational Study
Lead sponsor
Revent Medical International B.V.
Phase
Observational
Overall status
Terminated
Start date
September 30, 2014
Completion date
April 30, 2017
Enrollment
50 (estimated)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

obstructive sleep apnea